Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): A pragmatic randomised trial

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 8, 2014, Pages 887-892

  Beretta, Simone ^a   Beghi, Ettore ^b   Messina, Paolo ^b   Gerardi, Francesca ^b   Pescini, Francesca ^c   La Licata, Andrea ^c   Specchio, Luigi ^d   Ferrara, Mariangela ^d   Canevini, Maria Paola ^e   Turner, Katherine ^e   La Briola, Francesca ^e   Franceschetti, Silvana ^f   Binelli, Simona ^f   Giglioli, Isabella ^f   Galimberti, Carlo Andrea ^g   Fattore, Cinzia ^g   Zaccara, Gaetano ^h   Tramacere, Luciana ^h   Sasanelli, Francesco ⁱ   Pirovano, Marta ⁱ   Ferrarese, Carlo ^a   more..

^a SAN GERARDO HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f DEPARTMENT OF NEUROSURGERY   (Italy)

^g C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^h S MARIA NUOVA HOSPITAL   (Italy)

ⁱ Department of Pathology Servizio di Anatomia Patologica Ospedale di Circolo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG INTERACTION; EDUCATIONAL PLAN; EPILEPSY; FEMALE; HEALTH CARE; HEALTH CARE COST; HEALTH EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; UNSPECIFIED SIDE EFFECT; ADOLESCENT; BIOASSAY; CONTROLLED CLINICAL TRIAL; COST OF ILLNESS; ECONOMICS; METHODOLOGY; MIDDLE AGED; NEUROPHARMACOLOGY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT EDUCATION; SAMPLE SIZE; SOCIOECONOMICS; STATISTICAL ANALYSIS; STATISTICAL BIAS; TREATMENT OUTCOME; YOUNG ADULT;

ANTICONVULSANTS; EPILEPSY; NEUROPHARMACOLOGY;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; BIAS (EPIDEMIOLOGY); COST OF ILLNESS; DATA INTERPRETATION, STATISTICAL; DRUG INTERACTIONS; ENDPOINT DETERMINATION; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION AS TOPIC; PATIENT-CENTERED CARE; QUALITY OF LIFE; SAMPLE SIZE; SINGLE-BLIND METHOD; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904182948     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-306553     Document Type: Article

References (30)

1. Stefan H. Epilepsy in the elderly: facts and challenges. Acta Neurol Scand 2011;124:223-7.
2. Gaitatzis A, Carroll K, Majeed A, et al. The epidemiology and comorbidity of epilepsy in the general population. Epilepsia 2004;45:1613-22. (Pubitemid 39648287)
3. Collaborative Group for Epidemiology of Epilepsy. Adverse reactions to antiepileptic drugs: a follow-up study of 355 patients with chronic antiepileptic drug treatment. Epilepsia 1988;29:787-93.
4. Wilby J, Kainth A, Hawkins N, et al. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol Ass 2005;9:1-157.
5. Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol 2006;61:246-55. (Pubitemid 43382623)
6. Faught E. Monotherapy in adults and elderly persons. Neurology 2007;69:S3-9. (Pubitemid 350294666)
7. Thomsen LA, Winterstein AG, Sondergaard B, et al. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007;41:1411-26. (Pubitemid 47311361)
8. Leppik I. Epilepsy in the elderly. Epilepsia 2006;47(Suppl 1):65-70. (Pubitemid 44527138)
9. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002;36:1331-5.
10. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly. J Am Geriatr Socl 2002;50:1962-8. (Pubitemid 35462441)
11. Young SD, Oppenheimer DM. Different methods of presenting risk information and their influence on medication compliance intentions: results of three studies. Clin Ther 2006;28:129-39. (Pubitemid 43254997)
12. Greenfield S, Kaplan SH, Ware JE. Expanding patient involvement in care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med 1988;3:448-57.
13. Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of guided self-management and traditional treatment of asthma over one year. Br Med J 1996;312:748-52. (Pubitemid 26091240)
14. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003;(1): CD001117.
15. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001;24:561-87. (Pubitemid 32198430)
16. Weingart SN, Toth M, Eneman J, et al. Lessons from a patient partnership intervention to prevent adverse drug events. Internat J Qual Health Care 2004;16:499-507. (Pubitemid 39625159)
17. Roughead E, Pratt N, Peck R, et al. Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners. Pharmacoepidemiol Drug Saf 2007;16:797-803. (Pubitemid 47180369)
18. Freemantle N, Harvey EL, Wolf F, et al. Printed educational materials: effects on professional practice and health care outcome. Cochrane Database Syst Rev 2000; (2):CD000172.
19. Beghi E, Niero M, Roncolato M. Validity and reliability of the Italian version of the Quality-of-Life in Epilepsy Inventory (QOLIE-31). Seizure 2005;14:452-8. (Pubitemid 41548599)
20. Bender R, Lange S. Adjusting for multiple testing - when and how? J Clin Epidemiol 2001;54:343-9. (Pubitemid 32303457)
21. Mittan RJ. Psychosocial treatment programs in epilepsy: a review. Epilepsy Behav 2009;16:371-80.
22. Bradley PM, Lindsay B. Care delivery and self-management strategies for adults with epilepsy. Cochrane Database Syst Rev 2008;(1):CD006244.
23. Helgeson DC, Mittan R, Tan SY, et al. Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia 1990;31:75-82. (Pubitemid 20061090)
24. May TW, Pfäfflin M. The efficacy of an educational treatment program for patients with epilepsy (MOSES): results of a controlled, randomized study. Modular Service Package Epilepsy. Epilepsia 2002;43:539-49. (Pubitemid 34533712)
25. McAuley JW, Long L, Heise J, et al. A prospective evaluation of the effects of a 12-week outpatient exercise program on clinical and behavioral outcomes in patients with epilepsy. Epilepsy Behav 2001;2:592-600. (Pubitemid 33587022)
26. Helde G, Bovim G, Bråthen G, et al. A structured, nurse-led intervention program improves quality of life in patients with epilepsy: a randomized, controlled trial. Epilepsy Behav 2005;7:451-7. (Pubitemid 41614140)
27. Gilliam FG, Fessler AJ, Baker G, et al. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004;62:6-7.
28. Carreno M, Gil-Nagel A, Sanchez JC, et al. Strategies to detect adverse effects of antiepileptic drugs in clinical practice. Epilepsy Behav 2008;13:178-83.
29. Canevini MP, De Sarro G, Galimberti CA, et al. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 2010;51:797-804.
30. Cramer JA, Steinborn B, Striano P, et al. Non-interventional surveillance study of adverse events in patients with epilepsy. Acta Neurol Scand 2011;124:13-21.